Tech Company Financing Transactions
SpyGlass Ophthalmics Funding Round
SpyGlass Ophthalmics closed a $27 million Series B funding round on 1/11/2021. Investors included Vensana Capital and New Enterprise Associates.
Transaction Overview
Company Name
Announced On
1/11/2021
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series B
Investors
Vensana Capital (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
26431 Crown Valley Pkwy. 250
Mission Viejo, CA 92691
USA
Mission Viejo, CA 92691
USA
Phone
Website
Email Address
Not Recorded
Overview
SpyGlass Ophthalmics was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. The company is focused on the development of novel treatments for chronic ophthalmic diseases. The technology was originally developed in the Sue Anschutz-Rodgers Eye Center of the University of Colorado School of Medicine and spun off campus post Series A funding from New Enterprise Associates.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glenn Sussman
General Manager
James Dennewill
President
Malik Kahook
Browse more venture capital transactions:
Prev: 1/11/2021: Curlsmith venture capital transaction
Next: 1/11/2021: Hipcamp venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs